XBiotech (XBIT)
NASDAQ:XBIT
$16.96
-$0.11(-0.64%)
XBITXBiotech
$16.96
-$0.11 (-0.64%)

XBiotech Stock Analysis & Ratings

XBiotech Stock Analysis Overview

Smart Score
7
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The XBiotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, Data-Driven rating system and does not include human intervention.

Stock Chart

XBIT
$16.96
-$0.11 (-0.64%)

XBIT Stock Stats

Previous Close$17.07
Open$17.12
Bid16.5 x 1000
Ask17.4 x 1000
Today’s Range$16.88 - $17.12
52-Week Range$12.76 - $21.48
Volume60.79K
Average Volume74.23K
Market Cap$508.53M
Beta1.34
P/E Ratio-35.3
EPS-0.48

Company Description

XBiotech

XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
Sector
Healthcare
Industry
Biotechnology
CEO
John Simard
Employees
95
Address
5217 Winnebago Lane, Austin, TX, 78744, US

Financials

Currently, no data available
Please return soon as the page is updated accordingly.

P/E Ratio Range

Currently, no data available
Please return soon as the page is updated accordingly.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

XBIT FAQ

What was XBiotech’s price range in the past 12 months?
XBiotech lowest stock price was $12.76 and its highest was $21.48 in the past 12 months.
What is XBiotech’s market cap?
XBiotech’s market cap is $508.53M.
What is XBiotech’s price target?
Currently, no data Available
What do analysts say about XBiotech?
Not enough analysts have published a price target to provide an average price target.
When is XBiotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were XBiotech’s earnings last quarter?
Currently, no data Available
Is XBiotech overvalued?
According to Wall Street analysts XBiotech’s price is currently Overvalued.
Does XBiotech pay dividends?
XBiotech does not currently pay dividends.
What is XBiotech’s EPS estimate?
XBiotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does XBiotech have?
XBiotech has 29,980,000 shares outstanding.
What happened to XBiotech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of XBiotech?
Among the largest hedge funds holding XBiotech’s share is Caxton Associates LP. It holds XBiotech’s shares valued at 177K.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis